We are live on ! Find out more
ZJYL

Jin Medical International
ZJYL

Delisted

ZJYL was delisted on the 31st of July, 2026.

Back to rankings

18 hedge funds and large institutions have $2.98M invested in Jin Medical International in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 1

200% more funds holding

Funds holding: 6 → 18 (+12)

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

65% more capital invested

Capital invested by funds: $1.81M → $2.98M (+$1.17M)

0.07% less ownership

Funds ownership: 0.09% → 0.02% (-0.07%)

Holders
18
Holders Change
+12
Holders Change %
+200%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$1.4M
2
Invesco
Invesco
Georgia
+$1.04M
3
Millennium Management
Millennium Management
New York
+$559K
4
WG
Winton Group
United Kingdom
+$529K
5
Jane Street
Jane Street
New York
+$257K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$78.4K
2
Bank of America
Bank of America
North Carolina
-$2.73K
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
1
Marshall Wace
United Kingdom
$734K +$1.4M +9,554 New
Invesco
2
Invesco
Georgia
$544K +$1.04M +7,082 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$409K – – –
Millennium Management
4
Millennium Management
New York
$293K +$559K +3,820 New
WG
5
Winton Group
United Kingdom
$278K +$529K +3,614 New
XT
6
XTX Topco
Cayman Islands
$154K +$110K +749 +60%
Jane Street
7
Jane Street
New York
$135K +$257K +1,759 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$119K +$228K +1,556 New
SSA
9
Schonfeld Strategic Advisors
New York
$115K +$219K +1,495 New
JP Morgan Chase
10
JP Morgan Chase
New York
$81.2K +$132K +900 +573%
Two Sigma Investments
11
Two Sigma Investments
New York
$40.5K +$77.2K +528 New
HF
12
HRT Financial
New York
$40K +$77.1K +527 New
TRCT
13
Tower Research Capital (TRC)
New York
$32.7K +$61.3K +419 +5,986%
Morgan Stanley
14
Morgan Stanley
New York
$6.67K +$12.7K +87 New
UBS Group
15
UBS Group
Switzerland
$945 -$78.4K -536 -98%
BNP Paribas Financial Markets
16
BNP Paribas Financial Markets
France
$595 +$1.17K +8 New
Osaic Holdings
17
Osaic Holdings
Arizona
$154 +$293 +2 New
W
18
WealthCollab
Washington
$89 +$146 +1 New
Bank of America
19
Bank of America
North Carolina
– -$2.73K -11 Closed

ZJYL Hedge Fund Activity: Q1 2024 in Review

18 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q1 2024, worth a combined $2.98M — up 65% from $1.81M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ZJYL positions and 1 closed out — a net gain of 12 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $1.4M. The largest seller was UBS Group, cutting an estimated $78.4K.

  • 18 institutional investors held Jin Medical International (ZJYL) as of Q1 2024, up from 6 in Q4 2023.
  • Funds reported $2.98M of Jin Medical International stock for Q1 2024, up 65% quarter-over-quarter.
  • 13 funds opened new Jin Medical International positions in Q1 2024 and 1 closed out, a net change of +12 holders.
  • The largest Jin Medical International buyer in Q1 2024 was Marshall Wace, an estimated $1.4M added.
  • The largest Jin Medical International seller in Q1 2024 was UBS Group, an estimated $78.4K sold.

Based on aggregated 13F filings for Q1 2024.